A critical discovery in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This essential tumor protector protein is frequently disabled in several forms of tumors, causing uncontrolled https://bookmarkcolumn.com/story21732432/mini-antibodies-revive-the-p53-protein-new-promising-hope-for-malignant-therapy